Trojantec is a biopharmaceutical Company focused on identifying, in-licensing and developing innovative oncology therapeutics. Trojantec is one of a few Companies in the World developing drugs that not only attack Cancer Cells, but more importantly, destroy Cancer Stem Cells. Through research and development in this novel, exciting field, we wish to achieve the next order of magnitude of efficacy against cancer.